October 15, 2024

New Member: Welcome in our cluster to OMNI Life Science GmbH & Co. KG

New Member: Welcome in our cluster to OMNI Life Science GmbH & Co. KG
Go back

OLS – OMNI Life Science accelerates cell research with smart, reliable, and user-friendly technologies for life sciences and biotechnology. Their products are used in public, private, pharmaceutical, and biotech labs. The portfolio includes instruments, media, reagents, consumables, and services for Cell Counting, Culture, Imaging, Flow Cytometry, and Analysis. OLS supports researchers throughout the entire process, from conception to conclusion. They also offer instrument maintenance and provide training courses through their Life Science School.

If you would like to learn more, please visit their Website.
Looking forward to your active participation!

Our latest News

discover more
EMBL Council announces next EMBL Director General

EMBL Council announces next EMBL Director General

Anthony A. Hyman’s mandate to commence 31 March 2026 At its winter meeting, EMBL Council selected Anthony A. Hyman as EMBL’s next Director General.  “I am pleased to announce the decision by the EMBL Council to elect Anthony Hyman as future EMBL Director General,” said Peter Becker, EMBL Council Chair. “Tony witnessed the spirit of […]

read more
SPT Labtech enables automated PacBio Kinnex full-length RNA-seq library preparation workflow on SPT’s firefly platform

SPT Labtech enables automated PacBio Kinnex full-length RNA-seq library preparation workflow on SPT’s firefly platform

Cambridge, UK, 20 November 2025: SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, today announced a collaboration with Pacific Biosciences (PacBio), a pioneer in long-read sequencing, to automate PacBio’s Kinnex™ full-length RNA-seq library preparation on SPT Labtech’s firefly® liquid handling platform. The automated workflow will improve reproducibility […]

read more
Ovesco takes the next step in metabolic bariatric endoscopy and invests in Transduodenal Concepts

Ovesco takes the next step in metabolic bariatric endoscopy and invests in Transduodenal Concepts

Ovesco Endoscopy AG from Tübingen is investing almost € 1 million in the company Trans-Duodenal Concepts GmbH, Mannheim, to jointly promote innovative solutions in the field of metabolic-bariatric endoscopy. Around one billion people worldwide are affected by metabolic syndrome and its manifestations such as obesity, diabetes, hypertension and fatty liver disease. The Mannheim-based start-up Trans-Duodenal […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp